Welcome to PULSE by Wareable — and this week a dive into one of the most interesting new biowearable technologies on the horizon: continuous hormone monitoring.
The consumerization of biowearables has been a big talking point of 2024 with continuous glucose monitoring. And now a cohort of start-ups are looking to do the same for hormones — specifically for women’s health.
Tracking hormone levels would provide a window into many elements of women’s health, including fertility, menopause, and general wellness.
This week I’m joined by Anna O’Sullivan from FutureFemHealth. She talked through this game-changing new biowearable technology, the key start-ups, and why continuous hormone monitoring has the potential to change lives and drive commercial success, too.
You can listen to our chat as a podcast, or read the interview below:
In this newsletter:
What are Continuous Hormone Monitors?
How do CHMs work?
What insights could they offer?
The start-ups pioneering CHMs
State of women’s health wearables and US Election 2024 fallout
